Trokendi XR — Class II drug recall D-0112-2017
Terminated recall by Supernus Pharmaceuticals, Inc., reported 2016-10-26, distributed nationwide. Superpotent Drug: Failure of assay specifications in the capsule.
| Recall number | D-0112-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Supernus Pharmaceuticals, Inc., Rockville, MD, United States |
| Recall initiated | 2016-07-12 |
| Classified | 2016-10-20 |
| Reported by FDA | 2016-10-26 |
| Terminated | 2019-02-26 |
| Distributed | Nationwide (US) |
| Reason classes | potency |
| NDC | 17772-0102-15 |
| Lot numbers | 426636 |
| Expiration dates | 2018-04-22 |
Product
Trokendi XR (topiramate) extended-release capsule, 50mg, 30-count blister pack, Rx only, Manufactured by: Catalent Pharma Solutions, Winchester, KY 40391, Manufactured for: Supernus Pharmaceuticals, Inc., Rockville, MD 20850, NDC 17772-102-15
Reason for recall
Superpotent Drug: Failure of assay specifications in the capsule.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0112-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.